| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Garofalo Health Care S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.10 |
| 52 Week High | €5.46 |
| 52 Week Low | €3.95 |
| Beta | 0.46 |
| 11 Month Change | 2.20% |
| 3 Month Change | 5.59% |
| 1 Year Change | 26.55% |
| 33 Year Change | -7.94% |
| 5 Year Change | 21.28% |
| Change since IPO | 43.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| GHC | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -1.5% | -1.5% | 0.09% |
| 1Y | 26.6% | 0.8% | 3.1% |
Return vs Industry: GHC exceeded the German Healthcare industry which returned 0.8% over the past year.
Return vs Market: GHC exceeded the German Market which returned 3.1% over the past year.
Price Volatility
| GHC volatility | |
|---|---|
| GHC Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: GHC has not had significant price volatility in the past 3 months.
Volatility Over Time: GHC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 2,767 | Maria Garofalo | www.garofalohealthcare.com |
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation.
Garofalo Health Care S.p.A. Fundamentals Summary
| GHC fundamental statistics | |
|---|---|
| Market cap | €455.04m |
| Earnings (TTM) | €22.17m |
| Revenue (TTM) | €399.99m |
20.5x
P/E Ratio1.1x
P/S RatioIs GHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GHC income statement (TTM) | |
|---|---|
| Revenue | €399.99m |
| Cost of Revenue | €312.11m |
| Gross Profit | €87.88m |
| Other Expenses | €65.71m |
| Earnings | €22.17m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.25 |
| Gross Margin | 21.97% |
| Net Profit Margin | 5.54% |
| Debt/Equity Ratio | 73.7% |
How did GHC perform over the long term?
See historical performance and comparison